Identifying and overcoming protein secretion bottlenecks in yeast and filamentous fungal cell factories

识别并克服酵母和丝状真菌细胞工厂中的蛋白质分泌瓶颈

基本信息

  • 批准号:
    BB/F00446X/1
  • 负责人:
  • 金额:
    $ 53.8万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2007
  • 资助国家:
    英国
  • 起止时间:
    2007 至 无数据
  • 项目状态:
    已结题

项目摘要

Yeasts and moulds are both types of fungi. While yeasts such as Saccharomyces cerevisiae are widely regarded as useful because of its roles in making beer and wine, and in making bread, most moulds are regarded as a nuisance because they cause visible spoilage of foods, even though some species have uses in making valuable chemicals (e.g. penicillin). In fact, both yeasts and moulds are very important and are used commercially to make proteins that are not naturally produced by that fungus. In those cases, the gene that is necessary to make the protein is introduced into the fungus. Examples are insulin (for diabetics), chymosin (for cheese production) and a variety of enzymes used in food processing. Also, basic information about how enzymes work requires a plentiful supply of protein which usually means that those proteins are produced by a 'cell factory' such as a fungus. A common difficulty in making proteins from cell factories is that the yields are lower than desired. That is because the cell senses that it is being asked to make, and secrete to the outside of the cell, a protein which it wouldn't ordinarily make. The cell becomes stressed and it initiates a series of events within the cell aimed at protecting itself which, in so-doing, reduces the yield of protein secreted to the outside of the cell. Some proteins give rise to a bigger stress than others but we do not know the rules that govern the stress. This project aims to identify the rules and, thereby, understand how to predict which proteins will cause most stress and then to take steps with the 'cell factory' organisms to counteract the stress. In that way, we hope to be able to improve the cell factories to make more of the desired proteins. In particular, we aim to improve the capacity of fungal cell factories to produce antibody molecules that could be useful clinically.
酵母菌和霉菌都是真菌。虽然像酿酒酵母这样的酵母菌被广泛认为是有用的,因为它在酿造啤酒和葡萄酒以及制作面包方面起到了作用,但大多数霉菌被认为是一种滋扰,因为它们会导致食物的明显腐烂,尽管有些物种可以用来制造有价值的化学品(如青霉素)。事实上,酵母和霉菌都是非常重要的,在商业上被用来制造不是由这种真菌自然产生的蛋白质。在这种情况下,制造蛋白质所必需的基因被引入真菌中。例如胰岛素(用于糖尿病患者)、凝乳酶(用于奶酪生产)和食品加工中使用的各种酶。此外,有关酶如何工作的基本信息需要充足的蛋白质供应,这通常意味着这些蛋白质是由真菌等‘细胞工厂’产生的。从细胞工厂制造蛋白质的一个常见困难是产量低于预期。这是因为细胞感觉到它被要求制造一种它通常不会制造的蛋白质,并将其分泌到细胞外部。细胞变得紧张,它在细胞内启动了一系列旨在保护自己的事件,在这样做的过程中,减少了分泌到细胞外的蛋白质的产量。有些蛋白质会产生比其他蛋白质更大的压力,但我们不知道支配这种压力的规则。这个项目的目的是找出规律,从而了解如何预测哪些蛋白质会造成最大的压力,然后与“细胞工厂”的有机体一起采取措施来抵消压力。通过这种方式,我们希望能够改进细胞工厂,以生产更多所需的蛋白质。特别是,我们的目标是提高真菌细胞工厂生产可能在临床上有用的抗体分子的能力。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Investigating the physiological response of Pichia (Komagataella) pastoris GS115 to the heterologous expression of misfolded proteins using chemostat cultures.
  • DOI:
    10.1007/s00253-013-5186-1
  • 发表时间:
    2013-11
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Hesketh, Andrew R.;Castrillo, Juan I.;Sawyer, Trevor;Archer, David B.;Oliver, Stephen G.
  • 通讯作者:
    Oliver, Stephen G.
Process development for the continuous production of heterologous proteins by the industrial yeast, Komagataella phaffii.
  • DOI:
    10.1002/bit.26846
  • 发表时间:
    2018-12
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Cankorur-Cetinkaya A;Narraidoo N;Kasavi C;Slater NKH;Archer DB;Oliver SG
  • 通讯作者:
    Oliver SG
Yeast systems biology: the challenge of eukaryotic complexity.
酵母系统生物学:真核复杂性的挑战。
Global gene expression in recombinant and non-recombinant yeast Saccharomyces cerevisiae in three different metabolic states.
  • DOI:
    10.1016/j.biotechadv.2009.05.015
  • 发表时间:
    2009-11
  • 期刊:
  • 影响因子:
    16
  • 作者:
    H. Díaz;B. Andrews;A. Hayes;J. Castrillo;S. Oliver;J. Asenjo
  • 通讯作者:
    H. Díaz;B. Andrews;A. Hayes;J. Castrillo;S. Oliver;J. Asenjo
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen Oliver其他文献

Redundancy reveals drugs in action
冗余揭示药物的作用
  • DOI:
    10.1038/6748
  • 发表时间:
    1999-03-01
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Stephen Oliver
  • 通讯作者:
    Stephen Oliver
Exploring the impact of the pedestrian environment on public transportation: A case study of Waterloo Region
  • DOI:
  • 发表时间:
    2014-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stephen Oliver
  • 通讯作者:
    Stephen Oliver
A journey from bureaucracy to enterprise.
从官僚机构到企业的旅程。
  • DOI:
    10.1108/09552069610113327
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stephen Oliver;J. Harrison
  • 通讯作者:
    J. Harrison
Demand management in cells
细胞中的需求管理
  • DOI:
    10.1038/418033a
  • 发表时间:
    2002-07-04
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Stephen Oliver
  • 通讯作者:
    Stephen Oliver
Size is important, but…
尺寸很重要,但是……
  • DOI:
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    30.8
  • 作者:
    Stephen Oliver
  • 通讯作者:
    Stephen Oliver

Stephen Oliver的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen Oliver', 18)}}的其他基金

ConBioChem: Continuous bio-production of commodity chemicals
ConBioChem:大宗化学品的连续生物生产
  • 批准号:
    BB/N02348X/2
  • 财政年份:
    2021
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
A FAIR community resource for pathogens, hosts and their interactions to enhance global food security and human health
关于病原体、宿主及其相互作用的公平社区资源,以增强全球粮食安全和人类健康
  • 批准号:
    BB/S020098/1
  • 财政年份:
    2019
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
ConBioChem: Continuous bio-production of commodity chemicals
ConBioChem:大宗化学品的连续生物生产
  • 批准号:
    BB/N02348X/1
  • 财政年份:
    2016
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
European Partnering Award: Pichia pastoris as a vehicle for synthetic biology
欧洲合作奖:毕赤酵母作为合成生物学的载体
  • 批准号:
    BB/L026473/1
  • 财政年份:
    2014
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
Development of an integrated continuous process for recombinant protein production using Pichia pastoris
开发使用巴斯德毕赤酵母生产重组蛋白的集成连续工艺
  • 批准号:
    BB/K011138/1
  • 财政年份:
    2013
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
'13TSB_SynBio' Genome-scale metabolic modelling to optimise high value microbial manufacturing
“13TSB_SynBio”基因组规模代谢模型可优化高价值微生物制造
  • 批准号:
    BB/L004437/1
  • 财政年份:
    2013
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
Understanding the control of cell metabolism and growth in Saccharomyces cerevisiae through manipulation of purine nucleotide concentrations
了解通过操纵嘌呤核苷酸浓度对酿酒酵母细胞代谢和生长的控制
  • 批准号:
    BB/J01821X/1
  • 财政年份:
    2012
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant
A systems biology strategy for understanding the genome-wide control of growth rate and metabolic flux in yeast.
用于了解酵母生长速率和代谢通量的全基因组控制的系统生物学策略。
  • 批准号:
    BB/C505140/2
  • 财政年份:
    2007
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Research Grant

相似海外基金

Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
克服胰腺导管腺癌的治疗耐药机制
  • 批准号:
    10629062
  • 财政年份:
    2023
  • 资助金额:
    $ 53.8万
  • 项目类别:
BCCMA: Overcoming chemoresistance in ovarian cancer: Identification and validation of biomarkers and targetable drivers of platinum resistance
BCCMA:克服卵巢癌的化疗耐药性:铂类耐药的生物标志物和靶向驱动因素的识别和验证
  • 批准号:
    10585641
  • 财政年份:
    2023
  • 资助金额:
    $ 53.8万
  • 项目类别:
Overcoming pressure ulcers with engineered hormones and stem cells
用工程激素和干细胞克服压疮
  • 批准号:
    10821146
  • 财政年份:
    2023
  • 资助金额:
    $ 53.8万
  • 项目类别:
Overcoming the Inhibitory Neurovascular Niche in Preterm Infant Brain Injury
克服早产儿脑损伤中的抑制性神经血管生态位
  • 批准号:
    10657221
  • 财政年份:
    2023
  • 资助金额:
    $ 53.8万
  • 项目类别:
Overcoming proteasome impairment with small molecules
用小分子克服蛋白酶体损伤
  • 批准号:
    10427952
  • 财政年份:
    2022
  • 资助金额:
    $ 53.8万
  • 项目类别:
Overcoming FVIII protein misfolding and cell toxicity
克服 FVIII 蛋白错误折叠和细胞毒性
  • 批准号:
    10560541
  • 财政年份:
    2022
  • 资助金额:
    $ 53.8万
  • 项目类别:
Determining and Overcoming barriers in translating HIV-1 protease mediated activation of the CARD8 inflammasome to HIV cure research
确定并克服将 HIV-1 蛋白酶介导的 CARD8 炎性体激活转化为 HIV 治愈研究的障碍
  • 批准号:
    10749872
  • 财政年份:
    2022
  • 资助金额:
    $ 53.8万
  • 项目类别:
Determining and Overcoming barriers in translating HIV-1 protease mediated activation of the CARD8 inflammasome to HIV cure research
确定并克服将 HIV-1 蛋白酶介导的 CARD8 炎性体激活转化为 HIV 治愈研究的障碍
  • 批准号:
    10481087
  • 财政年份:
    2022
  • 资助金额:
    $ 53.8万
  • 项目类别:
Overcoming fluconazole resistance in Cryptococcus neoformans.
克服新型隐球菌中的氟康唑耐药性。
  • 批准号:
    472967
  • 财政年份:
    2022
  • 资助金额:
    $ 53.8万
  • 项目类别:
    Operating Grants
Overcoming drug resistance using small molecule activators of protein phosphatase 2A
使用蛋白磷酸酶 2A 小分子激活剂克服耐药性
  • 批准号:
    10513191
  • 财政年份:
    2022
  • 资助金额:
    $ 53.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了